MedTrace Logo

Handwriting Rehabilitation in Parkinson Disease

NCT02718560 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2017-04-04

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of an intensive handwriting treatment in Parkinson's Disease.

Conditions

  • Parkinson Disease
  • Neurorehabilitation
  • Handwriting

Interventions

BEHAVIORAL

Writing

Writing exercise with or without cues for 1 hour per day for 4 days at week for 4 weeks

Sponsors & Collaborators

  • Ospedale Generale Di Zona Moriggia-Pelascini

    lead OTHER

Principal Investigators

  • Giuseppe Frazzitta, MD · Ospedale Generale Di Zona Moriggia-Pelascini

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-06-30
Completion
2017-09-30

Countries

  • Italy

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718560 on ClinicalTrials.gov